Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
Provided By GlobeNewswire
Last update: Aug 20, 2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing
Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability
Read more at globenewswire.comNASDAQ:TRIB (10/28/2025, 1:44:03 PM)
1.02
0 (0%)
Find more stocks in the Stock Screener
